Kolonin, Gutierrez publish diabetes research in Cell Reports Medicine


By Roman Petrowski
December 7, 2022

Recent research from the labs of Mikhail Kolonin, PhD, and Absalon Gutierrez, MD, has been published in Cell Reports Medicine.

Recent research from the labs of Mikhail Kolonin, PhD, and Absalon Gutierrez, MD, has been published in Cell Reports Medicine. (Photo by Danny Palomba/Office of Communications)

A translational research study from collaborating laboratories of Mikhail Kolonin, PhD, and Absalon Gutierrez, MD, on the new mechanism mediating the anti-diabetic effects of incretins has been published in Cell Reports Medicine.

The global burden of Type 2 diabetes keeps rising in parallel with the increasing prevalence of obesity, a condition of white adipose tissue overgrowth. Frontline treatments include lifestyle changes, as well as the administration of insulin and of other glucose-lowering molecules that work through various mechanisms.

Read more…


Related topics